Key facts
- Dermanostic’s last known valuation is $2.0M (May 2020).
- It has raised $9.7M; the latest was Later Stage VC ($4.6M) in Jul 2025.
- Notable investors include STARTPLATZ, NRW BANK, Beiersdorf., Dieter von Holtzbrinck Ventures, EnjoyVenture — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Dermanostic
- ·The full record, as it builds
Funding rounds
No funding rounds for Dermanostic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dermanostic
Operator of the dermatology care platform intended to provide medical diagnosis and therapy recommendations. The company's application allows users to snap and upload a picture of their skin where they are experiencing some form of discomfort or irritation, and a dermatology specialist examines the case and sends the user a digital doctor's letter along with the respective diagnosis and therapy recommendation, enabling users to acquire dermatology services at their fingertips.
- Sector
- Healthcare
- HQ
- Solingen, Germany
- Founded
- 2019
- Employees
- 40
- Website
- dermanostic.com/
- Ownership
- Privately Held (backing)
Dermanostic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dermanostic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dermanostic in its N-PORT filings yet. We sweep new filings monthly.